Abstract:Background: Mitochondrial DNA depletion syndrome is an autosomal recessive disorder characterized by decreased mitochondrial DNA copy numbers in affected tissues. It has been linked to 4 genes involved in deoxyribonucleotide triphosphate metabolism: thymidine kinase 2 (TK2), deoxyguanosine kinase (DGUOK), polymerase gamma (POLG), and SUCLA2, the gene encoding the -subunit of the adenosine diphosphateforming succinyl coenzyme A synthetase ligase. Objective: To highlight the variability in the clinical spectrum… Show more
“…[1][2][3] However, the progression of weakness may vary, 4 as shown by recently described adult patients with late-onset myopathy. 5,6 To date, only 5 adult patients with TK2-related MDS have been reported.…”
Section: Tk2 Mutation Presenting As Indolent Myopathymentioning
“…[1][2][3] However, the progression of weakness may vary, 4 as shown by recently described adult patients with late-onset myopathy. 5,6 To date, only 5 adult patients with TK2-related MDS have been reported.…”
Section: Tk2 Mutation Presenting As Indolent Myopathymentioning
“…Other, less common, presentations include spinal muscular atrophylike presentation [13] and chronic progressive external ophthalmoplegia with proximal muscle weakness [23]. Milder presentations have been reported and include late onset proximal muscle weakness [15], adult-onset progressive myopathy [22], and sensorineural hearing loss [21].…”
Section: Tk2-related Myopathic Mdsmentioning
confidence: 99%
“…mtDNA content is typically severely reduced in muscle tissue. Electron transport chain (ETC) activity assays in skeletal muscle typically show decreased activity of multiple complexes with complex I, I + III, and IV being the most affected [13][14][15][16][17][18][19][20][21][22][23].…”
Mitochondrial DNA (mtDNA) depletion syndromes (MDS) are a genetically and clinically heterogeneous group of autosomal recessive disorders that are characterized by a severe reduction in mtDNA content leading to impaired energy production in affected tissues and organs. MDS are due to defects in mtDNA maintenance caused by mutations in nuclear genes that function in either mitochondrial nucleotide synthesis (TK2, SUCLA2,
“…Deficiency in TK2 activity is associated with the devastating mitochondrial DNA depletion syndrome, and the disease phenotype extends to the involvement of multiple organs beside skeletal muscle, as described in initial reports (1)(2)(3)(4)(5). TK2 is expressed in all tissues at low levels; however, little is known regarding TK2 regulation at the transcriptional, translational, and post-translational levels.…”
Background: Mitochondrial thymidine kinase 2 phosphorylates thymidine and deoxycytidine and is essential for mitochondrial function. Results: S-Glutathionylation of TK2 reduced activity in vitro and in vivo and affected its stability in H 2 O 2 -treated mitochondria and human cells. Conclusion: Oxidative stress induces mitochondrial TK2 S-glutathionylation and down-regulation. Significance: S-Glutathionylation is a new TK2 regulatory mechanism possibly contributing to mitochondrial diseases and aging.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.